Check out our most popular compounded medications! Get Started
The Estradiol 0.5 mg/Estriol 2 mg/Progesterone 50 mg/Testosterone 3.5 mg Slow Release (MEM4) Oral Capsules are a compounded formulation designed to provide a balanced combination of hormones for the management of menopausal symptoms, hormone replacement therapy, and other conditions related to hormone imbalances in women. Each capsule contains a precise dose of estradiol, estriol, progesterone, and testosterone, encapsulated with Methocel E4M, a controlled-release polymer.
Methocel E4M ensures that the hormones are released gradually over an extended period, which helps to maintain consistent hormone levels throughout the day, potentially reducing the incidence of peaks and troughs associated with immediate-release formulations. This slow-release mechanism offers sustained therapeutic effects, which can lead to improved patient compliance by reducing the dosing frequency. The use of this formulation may be particularly beneficial for patients experiencing menopausal symptoms such as hot flashes, night sweats, mood swings, and vaginal dryness, as well as for those requiring hormone replacement therapy.
By providing a controlled release of hormones, this formulation aims to alleviate the symptoms associated with hormone deficiencies or imbalances, while also considering the convenience and comfort of the patient. It is important to note that the use of this compounded formulation should be under the guidance and prescription of a healthcare professional, with dosages tailored to the individual needs of the patient.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The formulation in question combines bioidentical hormones estradiol, estriol, progesterone, and testosterone in specific doses to create a hormone replacement therapy (HRT) tailored for patients who may be experiencing symptoms associated with hormonal imbalances or deficiencies. Estradiol at 0.5 mg and estriol at 2 mg are forms of estrogen, a hormone that plays a critical role in women's health, influencing reproductive functions, bone density, and cardiovascular health. Progesterone at 50 mg is another key hormone that regulates menstruation and supports pregnancy. Testosterone at 3.5 mg, although typically considered a male hormone, is also important in women for maintaining muscle strength, bone density, and sexual function. The combination of these hormones can be used to address symptoms of menopause, such as hot flashes, night sweats, vaginal dryness, and mood swings, as well as to prevent osteoporosis and potentially reduce the risk of heart disease.
The use of Methocel E4M (hydroxypropyl methylcellulose) in this formulation is particularly noteworthy. This polymer is employed to create a slow-release (SR) or modified-release (MR) mechanism within the oral capsules. By incorporating Methocel E4M, the active ingredients are released gradually over time, which can lead to more stable hormone levels in the bloodstream, mimicking the body's natural release patterns. This controlled release can enhance the efficacy of the therapy by maintaining consistent therapeutic levels, minimizing the potential for peaks and troughs that could cause side effects or reduce the effectiveness of the treatment. Additionally, the slow-release design can improve patient compliance by reducing the frequency of dosing, which is often a significant factor in long-term treatment adherence.
This hormone combination therapy can be particularly beneficial for patients transitioning through menopause or those who have had a hysterectomy, as it can help in managing the symptoms associated with the loss of natural hormone production. It may also be prescribed for other hormone-related conditions as determined by a healthcare provider. It is important for prescribers to consider the individual needs of the patient, including their medical history, current health status, and specific symptoms, when determining the appropriateness of this HRT formulation.
For patients and prescribers interested in this custom-compounded HRT formulation, it is essential to engage in a thorough consultation to ensure the therapy is tailored to the patient's unique needs. Monitoring and adjustments may be necessary to achieve the best therapeutic outcomes. If you have any questions or require further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing in-depth guidance and support to ensure the safe and appropriate use of compounded medications.
The formulation you have described contains a combination of hormones: estradiol, estriol, progesterone, and testosterone, all of which are compounded into a slow-release capsule using Methocel E4M. This type of formulation is designed to treat hormone-related conditions by providing a steady release of hormones into the bloodstream, mimicking the body's natural hormone release patterns. It is important to consider potential drug interactions when prescribing or taking this medication.
Estradiol and estriol are forms of estrogen, and they can interact with a variety of medications. For example, they may reduce the effectiveness of aromatase inhibitors, which are used in the treatment of certain types of breast cancer. Concurrent use with thyroid hormone replacement therapy may necessitate adjustments in the thyroid medication dosage. Estrogens can also interfere with the metabolism of drugs processed by liver enzymes, such as CYP450, potentially leading to either increased or decreased levels of other medications.
Progesterone can interact with benzodiazepines, increasing their sedative effects. It may also affect the metabolism of certain drugs, including some anticonvulsants and antidepressants. Progesterone's interaction with other hormones, such as estrogen, can be complex and may require careful monitoring and dose adjustments.
Testosterone can interact with oral anticoagulants, potentially increasing the risk of bleeding. It may also affect blood sugar levels, which is particularly important for patients with diabetes; monitoring and possible adjustment of antidiabetic medication may be necessary. Additionally, testosterone can alter the effects of other hormones and may influence the metabolism of certain drugs through its impact on liver enzymes.
It is crucial to consider the overall health status of the patient and all other medications they are taking, including over-the-counter drugs and herbal supplements, as these can also interact with hormone therapy. Patients should be advised to inform all healthcare providers of their hormone therapy to avoid potential interactions. Regular monitoring and follow-up with the prescribing healthcare provider are essential to ensure the safe and appropriate use of this hormone combination therapy.
Given the complexity of hormone interactions with other drugs, prescribers should carefully evaluate the patient's medication profile for potential interactions before initiating therapy with this formulation. Adjustments to therapy may be necessary to avoid adverse effects or reduced efficacy of concurrent medications. If you have any questions or require further information regarding this formulation and its interactions, please reach out to us at Bayview Pharmacy.
The formulation of Estradiol 0.5 mg/Estriol 2 mg/Progesterone 50 mg/Testosterone 3.5 mg Slow Release (MEM4) Oral Capsules is a compounded medication that combines four hormones to address various conditions related to hormonal imbalances or deficiencies. The active ingredients in this formulation work synergistically to mimic the body's natural hormone levels and provide relief from symptoms associated with menopause, perimenopause, and other hormonal disorders. Estradiol and estriol are forms of estrogen, which is the primary female sex hormone responsible for regulating the menstrual cycle and maintaining the health of the reproductive system. Progesterone is another female hormone that plays a crucial role in the menstrual cycle and in maintaining the early stages of pregnancy. Testosterone, while typically considered a male hormone, is also present in females in smaller amounts and is important for maintaining muscle strength, bone density, and sexual function.
The use of Methocel E4M, a hydrophilic methylcellulose derivative, in these capsules allows for a slow and controlled release of the hormones into the body. Methocel E4M is a high-viscosity grade of hypromellose, which forms a gel-like matrix when it comes into contact with gastric fluids. This matrix creates a barrier that slows the rate at which the active ingredients are released from the capsule and absorbed into the bloodstream. The slow release mechanism ensures a more consistent serum hormone level over time, reducing the peaks and troughs associated with immediate-release formulations. This can lead to improved symptom control and a reduction in the potential for side effects that can occur with fluctuating hormone levels.
By providing a steady release of hormones, this formulation can help alleviate symptoms such as hot flashes, night sweats, vaginal dryness, mood swings, and decreased libido, which are often experienced during menopause or as a result of other hormonal imbalances. Additionally, the inclusion of testosterone in this formulation can help address issues of fatigue, weight gain, and diminished sexual desire that some women may experience. The use of a controlled-release system like Methocel E4M also means that patients may only need to take the medication once a day, which can greatly improve adherence to the treatment regimen.
It is important for both patients and prescribers to understand that this is a compounded medication, which means it is tailored to the specific needs of the patient and must be prescribed by a healthcare provider who has evaluated the individual's hormone levels and symptoms. Compounded medications are not FDA-approved but are prepared in compounding pharmacies that adhere to strict guidelines to ensure quality and safety. If you have any questions about this formulation or how it can be integrated into a treatment plan, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to provide guidance and support.
MEM4 Oral Capsules is a compounded formulation that contains Estradiol, Estriol, Progesterone, and Testosterone, all encompassed within a slow release capsule designed to deliver hormones in a controlled manner over time.
Methocel E4M capsules are designed with a controlled-release polymer that gradually releases the active ingredients over an extended period, ensuring sustained therapeutic levels in the body and improved patient compliance through reduced dosing frequency.
The primary benefits of using MEM4 Oral Capsules include more stable hormone levels throughout the day, a decreased risk of peaks and troughs associated with hormone intake, fewer doses required, and the convenience of not having to take medication as frequently.
This formulation includes Estradiol (0.5 mg), Estriol (2 mg), Progesterone (50 mg), and Testosterone (3.5 mg) within each capsule, providing a balanced mix for hormonal therapy.
MEM4 Oral Capsules are intended for individuals who require hormone replacement therapy and may benefit from a slow release formulation to manage their hormonal levels effectively.
Your healthcare provider will determine the appropriate dosing frequency based on your individual needs, but generally, the slow release nature of these capsules means they may be taken less frequently than immediate-release formulations.
All medications can have potential side effects, and hormone replacement therapy may include side effects such as mood swings, weight changes, or changes in libido. It's important to consult your healthcare provider for all possible side effects specific to your case.
Hormones can interact with other medications, supplements, or herbal preparations you may be taking. It's essential to inform your healthcare provider of all your medications to avoid interactions.
MEM4 Oral Capsules should be stored at room temperature, away from sunlight and moisture. Keep the capsules in their original container and out of reach of children.
Yes, since MEM4 is a compounded formulation, it can be tailored to the specific hormonal needs of an individual, under the guidance and prescription of a healthcare provider.
Yes, MEM4 Oral Capsules are a compounded medication and require a prescription from a licensed healthcare professional.
The onset of effects can vary depending on individual physiology and the specific hormonal balance required. It's best to have regular follow-ups with your healthcare provider to assess the effectiveness and make any necessary adjustments.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
